The names of the lead clinicians for the IRCI Fibrolamellar hepatocellular carcinoma group include:
Dr Michel Ducreux (EORTC)
Dr Marcio Malogolowkin (US)
Dr Tim Meyer (UK)
The fibrolamellar hepatocellular carcinoma group has decided that there is no immediate role for an interventional trial but instead are undertaking preparatory work outwith IRCI.